Xencor
Utility Patents
Last updated:
List of all Xencor patents 43 in total
| Status | Patent |
|---|---|
Grant | Utility: Heterodimeric Fc variants Filling date: 8 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof Filling date: 8 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases Filling date: 8 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Methods of treating neurological diseases Filling date: 8 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: IL-12 heterodimeric Fc-fusion proteins Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and CD38 Filling date: 8 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: CTLA4-IG immunoadhesins Filling date: 8 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Engineered IL-2 Fc fusion proteins Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Bispecific and monospecific antibodies using novel anti-PD-1 sequences Filling date: 8 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: CTLA4-Ig immunoadhesins Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Bispecific checkpoint inhibitor antibodies Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Heterodimeric antibodies that bind somatostatin receptor 2 Filling date: 8 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 8 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Fc variants with altered binding to FcRn Filling date: 8 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 8 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Modulation of T cells with bispecific antibodies and Fc fusions Filling date: 8 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains Filling date: 8 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Optimized antibody variable regions Filling date: 8 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Heterodimeric antibodies that bind fibroblast activation protein Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Optimized anti-CD3 variable regions Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 8 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and tumor antigens Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Bispecific antibodies that bind to CD38 and CD3 Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Heterodimeric human IgG1 polypeptides with isoelectric point modifications Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Bispecific checkpoint inhibitor antibodies Filling date: 8 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Complement component C5 antibodies Filling date: 8 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Optimized antibodies that target CD19 Filling date: 8 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Fc variants with increased affinity for Fc.gamma.RIIc Filling date: 8 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Anti-CD39 antibodies and uses thereof Filling date: 8 Sep 2025 Issue date: 11 Feb 2020 |
Grant | Utility: Bispecific heterodimeric fusion proteins containing IL-15-IL-15R.alpha. Fc-fusion proteins and PD-1 antibody fragments Filling date: 8 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Targeting regulatory T cells with heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Heterodimeric antibodies that bind CD3 and CD38 Filling date: 8 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Targeting regulatory T cells with heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: IL15/IL15R.alpha. heterodimeric Fc-fusion proteins Filling date: 8 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 26 Nov 2019 |
Grant | Utility: Heterodimeric proteins Filling date: 8 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Trispecific antibodies Filling date: 8 Sep 2025 Issue date: 1 Oct 2019 |
Showing 1 to 43 of 43 patents.